Interestingly, the SURPASS-2 trial found that patients on tirzepatide 5 mg experienced less nausea (17.4%) and vomiting (5.7%) compared to those on semaglutide 1 mg, who reported 19.2% nausea and 8.1% vomiting, despite tirzepatide leading to greater weight loss
Many employees will stop using them at some point
These findings are interesting, but they are not proof that GLP-1s prevent dementia
Choose a capsule that aligns with your dietary preferences.
It helps to reduce oxidative damage that occurs after physical activity, which can lead to faster recovery
The oral form of semaglutide, Rybelsus , further expands its reach, offering a non-injectable option, which appeals to a larger subset of patients who are hesitant about injections